Rachel C. Blitzblau MD
Breast Cancer
Associate Professor, Radiation Oncology, Duke University School of Medicine
Join to View Full Profile
566 RUIN CREEK RDHenderson, NC 27536
Dr. Blitzblau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Radiation Oncology, 2006 - 2010
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2005 - 2006
Tufts University School of MedicineClass of 2005
Certifications & Licensure
NC State Medical License 2010 - 2025
CT State Medical License 2008 - 2010
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Feasibility of Blood Oxygenation Level-Dependent Contrast (BOLD) Breast MRI Induced by Breath- Holding Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- Dermatofibrosarcoma Protuberans, Version 1.2025, NCCN Clinical Practice Guidelines In Oncology.Jeremy Bordeaux, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, Arya Amini
Journal of the National Comprehensive Cancer Network. 2025-01-01 - Understanding and modeling human-AI interaction of artificial intelligence tool in radiation oncology clinic using deep neural network: a feasibility study using three...Dongrong Yang, Cameron Murr, Xinyi Li, Sua Yoo, Rachel Blitzblau
Physics in Medicine and Biology. 2024-11-14 - 14 citationsNCCN Guidelines® Insights: Merkel Cell Carcinoma, Version 1.2024.Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, Arya Amini
Journal of the National Comprehensive Cancer Network. 2024-01-01
Journal Articles
- The Association of Extent of Axillary Surgery and Survival in Women with N2–3 Invasive Breast CancerJennifer K Plichta, Oluwadamilola M Fayanju, Rachel C Blitzblau, Rachel A Greenup, Laura H Rosenberger, E Shelley Hwang, Cecilia T Ong, Annals of Surgical Oncology
Press Mentions
New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every YearOctober 13th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
